SciBase Holding AB (publ) (STO:SCIB)

Market Cap	330.28M +313.3%
Revenue (ttm)	40.46M +36.2%
Net Income	-87.06M
EPS	-0.24
Shares Out	1.02B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	406,450
Average Volume	395,582
Open	0.3230
Previous Close	0.3230
Day's Range	0.3110 - 0.3390
52-Week Range	0.1850 - 0.5980
Beta	0.43
RSI	71.09
Earnings Date	Mar 13, 2026

About SciBase Holding AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Ne...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 46
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SCIB

Financial Performance

In 2025, SciBase Holding AB's revenue was 40.46 million, an increase of 36.21% compared to the previous year's 29.71 million. Losses were -87.06 million, 42.4% more than in 2024.